Trials / Sponsors / Jecho Biopharmaceuticals Co., Ltd.
Jecho Biopharmaceuticals Co., Ltd.
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological Non-Responders HIV | Phase 1 | 2026-05-30 |
| Recruiting | A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurre Recurrent Glioblastoma Multiforme(GBM) | Phase 1 / Phase 2 | 2026-04-01 |
| Not Yet Recruiting | A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle High Risk Non-muscle Invasive Bladder Cancer | Phase 1 | 2026-03-30 |
| Completed | A Phase I Study to Evaluate the Safety and Tolerability of JL15003 Injection in Patients With Recurrent Gliobl Recurrent Glioblastoma Multiforme(GBM) | Phase 1 | 2022-11-16 |
| Completed | A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD) Wet Age-related Macular Degeneration | Phase 3 | 2022-03-01 |